 |
PHARMACEUTICAL INDUSTRY :
Inventory and Distribution Network Analysis and Optimization |
|
| |
Client: |
|
A
global leader in the pharmaceutical industry with worldwide product
distribution. Division of a leading multinational pharmaceutical company. |
| |
|
|
|
| |
Problem: |
|
Assess
the optimal number of distribution centers for Europe and the U.S.
markets in order to maintain an optimal inventory level, and evaluate
impact on customer service and cost. |
| |
|
|
|
| |
Approach: |
|
Use
CAPS Supply Chain Designer to analyze the distribution network and
Extend software to simulate variations on inventory levels. Create
baseline scenarios for Europe and the U.S. with current levels of
inventory, transportation modes and sites. Develop optimization scenarios
for each evaluated market. In the U.S. and Europe, both multiple and
single DC scenarios were developed and evaluated. Level loading and
postponement strategies were also analyzed. A comparative analysis
of operations savings was conducted. |
| |
|
|
|
| |
Results: |
|
Implementation
of the optimal distribution network and inventory levels will lead
to:
• Inventory reduction of up to 40% in the U.S. and a reduction of
up to 33% in Europe
• 99.9% customer fulfillment in the U.S. and dramatic improvement
in fulfillment in Europe
• Reduction in DC network from five to two DCs in the U.S. and from
seven to three in Europe
• Total transportation costs reduced up to 34% compared with baseline |
| |
|
|
|
| |
 |
|
|
| |
|
|
|